The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1177/1078155214531514
dc.identifier.other
WOS:000357297600012
dc.description.volume
dc.description.issue
Publisher
SAGE PUBLICATIONS LTD
DOI
10.1177/1078155214531514